Cancidas

Merck Unveils Plan to Reclaim Leadership Position Dec 15, 2005
Business Wire (press release), ...$2.9 to $3.2 billion Other reported products* $5.9 to $6.2 billion * Other reported products comprise: AGGRASTAT, ARCOXIA, CANCIDAS, COSOPT, CRIXIVAN, EMEND ...